KLUS Pharma is Attending BioPharm America in Boston!

KLUS Pharma will attend the annual BioPharm America conference held in Boston, MA from September 28-29 and virtually from October 4-5, 2022. As part of Kelun-Biotech, a mid-sized innovative drug developer based in Chengdu, China, we are advancing a broad pipeline of small molecules, monoclonal antibodies, ADCs, and cell therapies covering various therapeutic areas, including oncology, autoimmune, metabolic, and cardiovascular diseases. With more than 10 projects in clinical trials and dozens of promising preclinical candidates under evaluation, we are seeking strategic partnerships to accelerate the development of these potential drug products on a global scale. We look forward to meeting potential next collaborators at the event!